Ruthsarian
Home
Sitemap
Q & A
Notice Board
PhEpi & PhV activities
Research Funding
Conferences & meetings
Recruitment
Links
Contact Us
Links to Data sources
Sr. No
Display Name
Type
Country
Last Updated
1
PHARMO Data Network
Data Source
Netherlands
04/01/2023
Links to Studies
Status
Official Title
Lead Investigator
Last Updated
Finalised
Impact of EU label changes and revised pregnancy prevention programme for medicinal products containing valproate: utilisation and prescribing trends
Professor Olaf Klungel
09/03/2023
Finalised
ACCESS template protocol for safety of COVID-19 vaccines
Professor Miriam Sturkenboom
09/01/2023
Finalised
Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination
Professor Miriam Sturkenboom
09/01/2023
Finalised
Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: utilization and prescribing trends
Dr Miriam Sturkenboom
09/11/2022
Finalised
Malignancies in Multiple Sclerosis: multi-country cohort database studies (feasibility study)
Dr Patrick Blin
05/04/2022
Finalised
Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids
Dr Jordi Castellsague
24/03/2022
Finalised
Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids
Dr Alejandro Arana
24/03/2022
Finalised
Dulaglutide Modified-Prescription-Event Monitoring Study and network database study: a multi-database collaborative research program of observational studies to monitor the utilisation and safety of dulaglutide in the EU
Professor Saad Shakir
11/11/2021
Finalised
A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the Netherlands
Dr Ron Herings
23/09/2021
Finalised
Intravenous Iron Postauthorisation Safety Study (PASS): Evaluation of the Risk of Severe Hypersensitivity Reactions
Mrs Lia Gutierrez
08/09/2021
Finalised
Impact of EU label changes for hydroxyzine products: post-referral prescribing trends
Professor Thomas MacDonald
06/01/2021
Finalised
Impact of EU label changes for systemic diclofenac products: post-referral prescribing trends
Professor Thomas MacDonald
16/02/2020
Finalised
Drug Utilisation Study for Olodaterol
Dr Alicia Gilsenan
21/01/2020
Finalised
Adherence, persistence and switching patterns – once- and twice-daily direct oral anticoagulants
Dr Ron Herings
19/12/2019
Finalised
Drug Utilization Study on Diane®-35 (and generics) in European healthcare databases
Dr CTP Team / Ref: "ENCePP"/ Bayer Pharma AG Bayer HealthCare AG
26/08/2019
Finalised
Drug utilization study of mirabegron (Betmiga®) using real-world healthcare databases from the Netherlands, Spain, United Kingdom and Finland
Dr Ron Herings
02/05/2019
Finalised
A PHARMO Study on the Utilization of Pioglitazone in Clinical Practice in The Netherlands with Regard to Diabetic Treatment Regimen and Co-morbidities
Dr Ron Herings
11/03/2019
Finalised
A multinational active safety surveillance study of crizotinib in Europe
Professor Henrik Toft Sørensen
18/07/2018
Finalised
Identification of type 2 diabetes cases in a set of databases participating to the EMIF project
Dr Roberto Giuseppe
11/12/2017
Finalised
Safety Evaluation of Adverse Reactions in Diabetes - Comparative studies
Professor Miriam Sturkenboom
25/08/2017
Finalised
Safety Evaluation of Adverse Reactions in Diabetes - Drug utilisation studies
Professor Miriam Sturkenboom
25/08/2017
Finalised
Arrhythmogenic Potential of Drugs
Professor Miriam Sturkenboom
25/08/2017
Finalised
Patterns and Determinants of Use of Oral Contraceptives in the European Union
Professor Miriam Sturkenboom
25/08/2017
Finalised
Risk of cardiac valve disorders associated with the use of biphosphonates
Professor Miriam Sturkenboom
25/08/2017
Finalised
Evaluation of the Use of Nepafenac in Selected European Populations
Dr Alejandro Arana Navarro
25/07/2017
Finalised
Pan European Multi-Database Bladder Cancer Risk Characterisation Study
Dr Pasi Korhonen
30/05/2017
Finalised
POST-APPROVAL SAFETY STUDY (PASS) OF THE UTILIZATION PATTERN OF APIXABAN IN THE NETHERLANDS
Dr Stephen Schachterle
28/07/2016
Finalised
Real-world effectiveness of extrafine vesrus standard particle inhaled corticosteroids: A comparative effectiveness analysis of extrafine (EF) hydrofluoroalkane beclometasone (HFA-BDP) and Ciclesonide versus commonly prescribed standard particle inhaled corticosteroids for patients prescribed asthma therapy in The Netherlands.
Dr Cristiana Miglio
21/01/2015
Ongoing
Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources
Professor Miriam Sturkenboom
09/01/2023
Ongoing
Comparison of the Risk of Cancer Between Patients With Type 2 Diabetes Exposed to Dapagliflozin and Those Exposed to Other Antidiabetic Treatments
Ms Lia Gutierrez
18/10/2022
Ongoing
FINErenone druG Utilization Study and assessment of Temporal changes following availability of different treatment options in patients with chronic kidney disease and type 2 diabetes
Dr Susana Perez-Gutthann
10/10/2022
Ongoing
An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using European Healthcare Data through VAC4EU (COVID-19)
Professor Miriam Sturkenboom
05/09/2022
Ongoing
A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources (COVID-19)
Dr Cristina Rebordosa
24/08/2022
Ongoing
A Retrospective Cohort Study to Assess Drug Utilisation and Long-Term Safety of Galcanezumab in European Patients in the Course of Routine Clinical Care
Dr Krista Schroeder
30/07/2020
Ongoing
Estimating prevalence and incidence of acute myocardial infarction in a set of heterogeneous sources of observational health data collaborating in the EMIF Platform
Dr Roberto Giuseppe
14/02/2019
Planned
The BRodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) study in electronic healthcare databases
Professor Jesper Hallas
05/10/2021
News
About Us
ENCePP Documents
Training in PhEpi and PV
Code of Conduct
Standards & Guidances
ENCePP Study Seal
Public Consultation
Glossary of terms
Resources Database
Partners forum
EU PAS Register
About EU PAS Register